Intuitive Surgical's powerful growth is running headlong into some serious market challenges, and how management framed the collision tells you everything about the real risks.

Zimmer Biomet Holdings has appointed Chintan Desai as president of its Asia Pacific region, effective July 14, 2026, succeeding long-serving leader Sang Yi after a transition period ending August 28, 2026. Desai’s three decades of MedTech and regional leadership experience across Asia Pacific, spanning Alcon and GE Healthcare, could meaningfully influence Zimmer Biomet’s execution in one of its most important international healthcare markets. Now we’ll examine how Desai’s appointment to lead...

Zimmer Biomet Holdings (ZBH) drew investor attention after appointing Chintan Desai as president of its Asia Pacific region, a key geography for the medical technology company’s global footprint and long term plans. See our latest analysis for Zimmer Biomet Holdings. The executive change comes as Zimmer Biomet Holdings trades at US$91.03, with a 7 day share price return of 1.81% and a 30 day share price return of 2.78%, while the 1 year total shareholder return has declined 2.17% and the 3...

Here is a way to get paid a meaningful income now on your Intuitive Surgical shares, cash you keep no matter what, in exchange for capping your gains at a price above today's.

This is a product-cycle year for Intuitive Surgical. The company's growth is fueled by hospitals and surgeons adopting its new da Vinci 5 and existing Ion robotic systems.

Conmed stock rocketed closer to breakout territory Monday on reports the medtech company is exploring a possible sale.